skip to Main Content

We make human cells

New paradigm for drug toxicity screening efficent and ultimate therapy for diseases

Data sheets

NEXEL’s Data sheets

Cardiosight®-S Poster - SPS2019 Evaluation of Human iPS Cell-Derived Cardiomyocytes in High-Throughput Toxicity Screening Appli

Author
nexeladmin
Date
2020-05-28 13:58
Views
339
Evaluation of Human iPS Cell-Derived Cardiomyocytesin High-Throughput Toxicity Screening Applications

Gunsik Cho1, Hyosung Kwon1, Dongkyu Kim1, András Horváth2, Nadine Becker2, Krisztina Juhász2, Elena Dragicevic2 and Sonja Stoelzle-Feix2
1NEXEL Co., Ltd, Seoul, South Korea, 2Nanion Technologies GmbH, München, Germany

 

Poster Presentation for SPS 2019 in Barcelona
Back To Top